Eko Low Ejection Fraction Tool (ELEFT) vs IM007
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
The Eko Low Ejection Fraction Tool (ELEFT) is designed for early, non-invasive detection of low ejection fraction during routine physical exams using a digital stethoscope. In contrast, IM007 by Implicity is a remote monitoring platform that aggregates data from cardiac implantable electronic devices (CIEDs) to manage existing cardiac conditions and predict heart failure hospitalization risk. While both leverage AI in cardiology for heart failure, they address different stages of patient care and utilize distinct data sources, making them complementary rather than direct competitors.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Eko Low Ejection Fraction Tool (ELEFT) is designed for integration into routine physical exams to screen for low ejection fraction in a broad patient population, providing results in approximately 15 seconds. IM007 is a remote monitoring platform specifically for patients with cardiac implantable electronic devices (CIEDs), streamlining data aggregation and alert management post-implantation.
IM007 explicitly offers robust EHR integration capabilities through a bidirectional API and an integration framework. ELEFT is part of Eko's SENSORAu2122 platform, which offers EHR customization and cloud-based data processing and storage, implying data accessibility for integration.
IM007 provides specific metrics for its AI, such as reducing false positives by 79% for its ILR ECG Analyzer and 85% for AF alerts, and includes SignalHF for predictive heart failure hospitalization risk. ELEFT was clinically validated in a multi-site study of 3,456 patients, achieving an AUROC of 0.835 for detection of LVEF <40%, with 74.7% sensitivity and 77.5% specificity.
IM007 explicitly highlights its 'multi-centric capabilities,' indicating it is designed to support deployment across various sites. ELEFT is part of Eko's SENSORAu2122 platform, an enterprise solution designed to help health systems scale AI-powered cardiac disease detection across specialties, and has been deployed in over 100 clinics in London and Wales.
ELEFT integrates with familiar Eko digital stethoscopes and provides quick results in 15 seconds, suggesting a potentially low learning curve for clinicians during routine physical exams. IM007, while a comprehensive platform, features smart workflow automation to streamline processes, and both companies would typically offer support, with Eko's SENSORAu2122 platform including on-site training and a dedicated customer success manager.
The provided descriptions do not explicitly detail specific audit trail or comprehensive reporting features for either tool. However, as enterprise solutions handling sensitive patient data, such capabilities are generally expected for accountability and compliance in clinical settings. Eko's SENSORAu2122 platform does include an Admin Dashboard for centralized data management.
More Comparisons
Backers
Who funded each tool's parent company.